Type
1.
van Hooij A, van den Eeden SJF, Khatun M, Soren S, Franken KLMC, Roy JC, et al. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease. Vaccine [Internet]. 2021; Available from: https://www.sciencedirect.com/science/article/pii/S0264410X21013487?via%3Dihub
Type
1.
Tavares IF, Dos Santos JB, Pacheco FDS, Gandini M, Mariante RM, Rodrigues TF, et al. Mycobacterium leprae Induces Neutrophilic Degranulation and Low-Density Neutrophil Generation During Erythema Nodosum Leprosum. Frontiers in medicine [Internet]. 2021;8:711623. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531262/pdf/fmed-08-711623.pdf
Type
1.
Naidu P, Sharma R, Kanji JN, Marks V, King A. Autochthonous North American Leprosy: A Second Case in Canada. Infectious disease reports [Internet]. 2021;13(4):917-23. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544447/pdf/idr-13-00083.pdf
Type
1.
Tomaselli PJ, Santos DFD, Santos ACJD, Antunes DE, Marques VD, Foss NT, et al. Primary neural leprosy: clinical, neurophysiological and pathological presentation and progression. Brain : a journal of neurology. 2021;
Type
1.
Filho FB, Lima FR, Voltan G, de Paula NA, Cipriani Frade M. Leprosy case series in the emergency room: A warning sign for a challenging diagnosis. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Internet]. 2021;:101634. Available from: https://www.sciencedirect.com/science/article/pii/S1413867021001033?via%3Dihub
Type
1.
Dellar R, Ali O, Kinfe M, Tesfaye A, Fekadu A, Davey G Centre for Global Health Research, Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, UK, School of Public Health, College of Health Sciences, Addis Ababa University, P.O. Box 9086, Ethiopia, et al. Knowledge, attitudes and practices of health professionals towards people living with lymphoedema caused by lymphatic filariasis, podoconiosis and leprosy in northern Ethiopia. International health [Internet]. 2021; Available from: https://academic.oup.com/inthealth/advance-article-pdf/doi/10.1093/inthealth/ihab067/40564066/ihab067.pdf
Type
1.
Hazarika N, Gupta PK, Dhanta A, Singh A, Mohanty A, Gupta P. Renaissance of Hansen’s Disease in Post-Elimination Era in North India: A Retrospective Clinico-Bacteriological Study. Cureus [Internet]. 2021;13(8):e17514. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476198/pdf/cureus-0013-00000017514.pdf
Type
1.
Sharma M, Singh P. Repurposing Drugs to Combat Drug Resistance in Leprosy: A Review of Opportunities. Combinatorial chemistry & high throughput screening. 2021;
Type
1.
Deps P, Collin SM. Mycobacterium lepromatosis as a Second Agent of Hansen’s Disease. Frontiers in microbiology [Internet]. 2021;12:698588. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461103/pdf/fmicb-12-698588.pdf
Type
1.
Eze CC, Ekeke N, Alphonsus C, Lehman L Retired American Leprosy Missions, Rio Rancho, New Mexico, USA\newline e-mail: lfayelehman@gmail.com, Chukwu JN, Nwafor CC, et al. Effectiveness of self-care interventions for integrated morbidity management of skin neglected tropical diseases in Anambra State, Nigeria. BMC public health [Internet]. 2021;21(1):1748. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8465703/pdf/12889_2021_Article_11729.pdf
Pagination
- Previous page
- Page 36
- Next page